Resources

The selective inhibitor of dipeptidyl peptidase IV (DPP-4), vildagliptin, promotes reduction of plasma glucose levels in patients with type 2 diabetes by suppressing endogenous glucose production and augmenting insulin secretion.

A history of migraine and other headache types has been linked to an increased prevalence of retinopathy in middle-aged individuals, supporting the hypothesis that neurovascular dysfunction underlies vascular headaches.

An oversupply of fatty acids plays a key role in the development of insulin resistance in the skeletal muscle of obese individuals.

The introduction of new treatment options and a growing number of diabetes patients will drive costs upward

The first serum glucose level measured in the emergency department is an independent prognostic factor in patients who have sustained a first acute myocardial infarction, researchers report.

Scientists have discovered a key aspect of how embryos create the cells that secrete insulin.

The number of adolescent girls taking drugs for Type 2 diabetes nearly tripled in just five years.

Preterm babies born at very low birth weight may be more prone blood sugar problems as young adults.

Looking at various proteins in urine may help doctors predict the development of diabetic nephropathy in type 2 diabetes patients well before they develop the condition.

Treatment with twice-daily insulin detemir or once-daily insulin glargine, each in combination with insulin aspart, resulted in similar glycemic control.